cyclic-gmp and octylmethoxycinnamate

cyclic-gmp has been researched along with octylmethoxycinnamate* in 1 studies

Other Studies

1 other study(ies) available for cyclic-gmp and octylmethoxycinnamate

ArticleYear
UV-B Filter Octylmethoxycinnamate Induces Vasorelaxation by Ca
    International journal of molecular sciences, 2019, Mar-19, Volume: 20, Issue:6

    Ultraviolet (UV) filters are chemicals widely used in personal care products (PCPs). Due to their effect as endocrine disruptor compounds (EDCs), the toxicity of UV filters is a current concern for human health. EDC exposure may be correlated to cardiovascular diseases (CVD), but to our knowledge, no studies assessed the UV filters effects as human EDCs at the vascular level. Octylmethoxycinnamate (OMC) is the world's most widely used UV-B filter, present in more than 90% of PCPs. Due to its demonstrated multiple hormonal activities in animal models, this substance is also suspected to be a human EDC. The purpose of this study was to assess the rapid/short-term effects of OMC on arterial tonus and analyse its mode of action (MOA). Using human umbilical arteries, the endocrine effects of OMC were evaluated in in vitro (cellular and organ) experiments by planar cell surface area (PCSA) and organ bath, respectively. Our data show that OMC induces a rapid/short-term smooth muscle relaxation acting through an endothelium-independent MOA, which seems to be shared with oestrogens, involving an activation of soluble guanylyl cyclase (sGC) that increases the cyclic guanosine monophosphate (cGMP) intracellular levels and an inhibition of L-type voltage-operated Ca

    Topics: Calcium Channel Blockers; Cinnamates; Cyclic GMP; Enzyme Activation; Humans; Models, Biological; Myocytes, Smooth Muscle; Soluble Guanylyl Cyclase; Ultraviolet Rays; Umbilical Arteries; Vasoconstriction; Vasodilation

2019